Loading clinical trials...
Loading clinical trials...
The objective of this study is to determine the safety and effectiveness of the IDEAL IMPLANT in women who are undergoing primary breast augmentation or replacement of existing saline-filled or silico...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Ideal Implant Incorporated
NCT04220970 · Anaplastic Large Cell Lymphoma Associated With Breast Implants (BIA-ALCL)
NCT04255810 · Women With Breast Implants With and Without Self-reported Systemic Symptoms, Women Undergoing an Elective Mastopexy (Breast Lift) or Small Reduction
NCT04302233 · Joint Prosthesis, Breast Implants, and more
NCT06147661 · Breast Implants
NCT01857765 · Breast Implants, Surgery, Plastic
Beverly Hills, California
Folsom, California
Huntington Beach, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions